Safety surveillance and the introduction of pathogen reduced platelets
Dr. John Pitman, PhD Cerus Corporation Concord, USA
Ordering platelet concentrates: does pathogen inactivation matter to the clinician?
Prof. Dr. Helmut Ostermann, LMU Kliniken University of Munich Munich, Germany
Transfusion transmitted bacterial infections in patients: why are they often undetected and underreported?
Dr. Richard J. Benjamin, MBChB, PhD, FRCPath Cerus Corporation Concord, California, USA